Acute palliative care unit-initiated interventions for advanced cancer patients at the end of life: prediction of impending death based on Glasgow Prognostic Score.
Acute palliative care unit
Glasgow Prognostic Score
Palliative care
Prognostication
Thrombocytopenia
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
17
04
2020
accepted:
16
07
2020
pubmed:
1
8
2020
medline:
9
3
2021
entrez:
1
8
2020
Statut:
ppublish
Résumé
Unexpected death occurred in an unexpectedly high proportion of advanced cancer patients in the acute palliative care unit (APCU) setting and associated with fewer signs of impending death. Recognition of patients at high risk of approaching death, especially immediately after admitting APCU among clinicians, can improve the end-of-life trajectory. Our objective was accurate prognostication within a few days of admission. Patients admitted to an APCU of the NTT Medical Center Tokyo, Tokyo, Japan, between April 2009 and December 2016 were retrospectively examined. The Glasgow Prognostic Score (GPS) was optimized with concomitant neutrophilia, lymphocytopenia, thrombocytopenia, anemia, and monocytosis. Kaplan-Meier survival curves were estimated, and independent predictors for 3-day mortality were identified using univariate and multivariate analyses. The sensitivity, specificity, and likelihood ratios (LRs) associated with imminent death were also assessed. Nine hundred ninety-one patients were included; 52.9% was male. The median age was 72 years. The median survival was 13 days (IQ range 6 to 26), and 11.7% died within 3 days of admission. Significant difference in survival with a GPS of 2 was observed in GPS optimized with concomitant thrombocytopenia, and it was the only significant predictor associated with 3-day mortality (p = 0.004), which had high specificity (> 95%) and high positive LR (> 5). The prognostic value of the GPS was enhanced by adding thrombocytopenia. The concurrent use of the GPS and platelet count improved the prognostication of limited time of survival and could assist in the personal and clinical decisions for advanced cancer patients.
Identifiants
pubmed: 32734391
doi: 10.1007/s00520-020-05638-z
pii: 10.1007/s00520-020-05638-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1557-1564Références
Bruera S, Chisholm G, Santos RD, Bruera E, Hui D (2014) Frequency and factors associated with unexpected death in an acute palliative care unit: expect the unexpected. J Pain Symptom Manag 49(5):822–827. https://doi.org/10.1016/j.jpainsymman.2014.10.011
doi: 10.1016/j.jpainsymman.2014.10.011
Am B, Haley WE, Small BJ (2006) Bereavement after caregiving or unexpected death: effects on elderly spouses. Aging Ment Health 10(3):319–326. https://doi.org/10.1080/13607860500410045
doi: 10.1080/13607860500410045
Bradley EH, Prigerson H, Carlson MD, Cherlin E, Johnson-Hurzeler R, Kasl SV (2004) Depression among surviving caregivers: does length of hospice enrollment matter? Am J Psychiatry 161(12):2257–2262. https://doi.org/10.1176/appi.ajp.161.12.2257
doi: 10.1176/appi.ajp.161.12.2257
pubmed: 15569897
Hui D, Paiva CE, Del Fabbro EG, Steer C, Naberhuis J, van de Wetering M, Fernández-Ortega P, Morita T, Suh SY, Bruera E, Mori M (2019) Prognostication in advanced cancer: update and directions for future research. Support Care Cancer 27(6):1973–1984. https://doi.org/10.1007/s00520-019-04727-y
doi: 10.1007/s00520-019-04727-y
pubmed: 30863893
pmcid: 6500464
Gripp S, Moeller S, Bölke E, Scmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R (2007) Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25(22):3313–3320. https://doi.org/10.1200/JCO.2006.10.5411
doi: 10.1200/JCO.2006.10.5411
pubmed: 17664480
Amano K, Maeda I, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Ono S, Yamamoto R, Yamamoto N, Shishido H, Shimizu M, Kawahara M, Aoki S, Demizu A, Goshima M, Goto K, Gyoda Y, Hashimoto K, Otomo S, Sekimoto M, Shibata T, Sugimoto Y, Morita T (2015) The accuracy of physicians’ clinical predictions of survival in patients with advanced cancer. J Pain Symptom Manag 50(2):139–146.e1. https://doi.org/10.1016/j.jpainsymman.2015.03.004
doi: 10.1016/j.jpainsymman.2015.03.004
Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320(7233):469–472. https://doi.org/10.1136/bmj.320.7233.469
doi: 10.1136/bmj.320.7233.469
pubmed: 10678857
pmcid: 27288
Maltoni M, Amadori D (2002) Prognosis in advanced cancer. Hematol Oncol Clin North Am 16(3):715–729. https://doi.org/10.1016/S0889-8588(02)00024-2
doi: 10.1016/S0889-8588(02)00024-2
pubmed: 12170577
Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manag 17(4):231–239. https://doi.org/10.1016/S0885-3924(98)00145-6
doi: 10.1016/S0885-3924(98)00145-6
Morita T, Tsunoda J, Inoue S, Chihara S (1999) The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7(3):128–133. https://doi.org/10.1007/s005200050242
doi: 10.1007/s005200050242
pubmed: 10335930
Yamada T, Morita T, Maeda I, Inoue S, Ikenaga M, Matsumoto Y, Baba M, Sekine R, Yamaguchi T, Hirohashi T, Tajima T, Tatara R, Watanabe H, Otani H, Takigawa C, Matsuda Y, Ono S, Ozawa T, Ymamoto R, Shishido H, Yamamoto N (2017) A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists. Cancer 123(8):1442–1452 https://10.1002/cncr.30484
doi: 10.1002/cncr.30484
Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, Barclay S, Stone PC (2015) Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. BMJ Support Palliat Care 5(4):390–398. https://doi.org/10.1136/bmjspcare-2012-d4020rep
doi: 10.1136/bmjspcare-2012-d4020rep
pubmed: 26586684
Chiang JK, Lai NS, Wang MH, Chen SC, Kao YH (2009) A proposed prognostic 7-day survival formula for patients with terminal cancer. BMC Public Health 9:365. https://doi.org/10.1186/1471-2458-9-365
doi: 10.1186/1471-2458-9-365
pubmed: 19785768
pmcid: 2761894
Hui D, Hess K, dos Santos R, Chisholm G, Bruera E (2015) A diagnostic model for impending death in cancer patients: preliminary report. Cancer 121(21):3914–3921. https://doi.org/10.1002/cncr.29602
doi: 10.1002/cncr.29602
pubmed: 26218612
pmcid: 4618185
Diakos CI, Charles KA, McMillan DC, Clarke SJ (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15(11):e493–e503. https://doi.org/10.1016/S1470-2045(14)70263-3
doi: 10.1016/S1470-2045(14)70263-3
pubmed: 25281468
MacDonald N (2011) Chronic inflammatory states: their relationship to cancer prognosis and symptoms. J R Coll Physicians Edinb 41(3):246–253. https://doi.org/10.4997/JRCPE.2011.315
doi: 10.4997/JRCPE.2011.315
pubmed: 21949925
McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226. https://doi.org/10.1097/MCO.0b013e32832a7902
doi: 10.1097/MCO.0b013e32832a7902
pubmed: 19318937
Simmons CPL, McMillan DC, McWilliams K, Sande TA, Fearon KC, Tuck S, Fallon MT, Laird BJ (2017) Prognostic tools in patients with advanced cancer: a systematic review. J Pain Symptom Manag 53(5):962–970. https://doi.org/10.1016/j.jpainsymman.2016.12.330
doi: 10.1016/j.jpainsymman.2016.12.330
Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC (2017) The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 116:134–146. https://doi.org/10.1016/j.critrevonc.2017.06.002
doi: 10.1016/j.critrevonc.2017.06.002
pubmed: 28693795
Fan H, Shao ZY, Xiao YY, Xie ZH, Chen W, Xie H, Qin GY, Zhao NQ (2016) Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. J Cancer Res Clin Oncol 142(6):1285–1297. https://doi.org/10.1007/s00432-015-2113-0
doi: 10.1007/s00432-015-2113-0
pubmed: 26864695
Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Morita T, Kinoshita H (2015) Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Support Care Cancer 23(11):3149–3156. https://doi.org/10.1007/s00520-015-2693-x
doi: 10.1007/s00520-015-2693-x
pubmed: 25777319
McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5):534–540. https://doi.org/10.1016/j.ctrv.2012.08.003
doi: 10.1016/j.ctrv.2012.08.003
pubmed: 22995477
pmcid: 22995477
Dogan M, Algin E, Guven ZT, Baykara M, Kos TF, Bal O, Zengin N (2018) Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer? Curr Med Res Opin 34(5):857–863. https://doi.org/10.1080/03007995.2017.1408579
doi: 10.1080/03007995.2017.1408579
pubmed: 29161926
Nakamura Y, Watanabe R, Katagiri M, Saida Y, Katada N, Watanabe M, Okamoto Y, Asai K, Enomoto T, Kiribayashi T, Kusachi S (2016) Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer. World J Surg Oncol 14:148. https://doi.org/10.1186/s12957-016-0904-7
doi: 10.1186/s12957-016-0904-7
pubmed: 27184053
pmcid: 4867538
Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy RH, Faiz OD, Aziz O, Jenkins JT (2014) A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg 260(2):287–292. https://doi.org/10.1097/SLA.0000000000000216
doi: 10.1097/SLA.0000000000000216
pubmed: 24096764
Nakayama M, Gosho M, Hirose Y, Nishimura B, Tanaka S, Tabuchi K, Okubo H, Wada T, Hara A (2018) Modified combination of platelet count and neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer. Head Neck 40(6):1138–1146. https://doi.org/10.1002/hed.25085
doi: 10.1002/hed.25085
pubmed: 29385295
Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2013) Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 109(2):401–407. https://doi.org/10.1038/bjc.2013.350
doi: 10.1038/bjc.2013.350
pubmed: 23820256
pmcid: 3721384
Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC (2013) Optimization of the systemic inflammation-based Glasgow Prognostic Score: a Glasgow Inflammation Outcome Study. Cancer 119(12):2325–2332. https://doi.org/10.1002/cncr.28018
doi: 10.1002/cncr.28018
pubmed: 23575969
Hui D, Elsayem A, Palla S, De La Cruz M, Li Z, Yennurajalingam S, Bruera E (2010) Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med 13(1):49–57. https://doi.org/10.1089/jpm.2009.0166
doi: 10.1089/jpm.2009.0166
pubmed: 19824813
pmcid: 2883821
Chen BH, Sham MM, Chan KY, Li CW, Au HY (2015) Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life. Am J Hosp Palliat Care 32(2):221–225. https://doi.org/10.1177/1049909113512412
doi: 10.1177/1049909113512412
Pace A, Metro G, Fabi A (2010) Supportive Care in Neurooncology. Curr Opin Oncol 22(6):621–626. https://doi.org/10.1097/CCO.0b013e32833e078c
doi: 10.1097/CCO.0b013e32833e078c
pubmed: 20706120
Chen YT, Ho CT, Hsu HS, Huang PT, Lin CY, Liu CS, Li TC, Lin CC, Lin WY (2015) Objective palliative prognostic score among patients with advanced cancer. J Pain Symptom Manag 49(4):690–696. https://doi.org/10.1016/j.jpainsymman.2014.08.017
doi: 10.1016/j.jpainsymman.2014.08.017
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DL (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89(6):1028–1030. https://doi.org/10.1038/sj.bjc.6601242
doi: 10.1038/sj.bjc.6601242
pubmed: 12966420
pmcid: 2376960
Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, Klepstad P (2013) Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19(19):5456–5464. https://doi.org/10.1158/1078-0432.CCR-13-1066
doi: 10.1158/1078-0432.CCR-13-1066
pubmed: 23938289
Baranyai Z, Jósa V, Tóth A, Szilasi Z, Tihanyi B, Zaránd A, Harsanyi L, Szállási Z (2016) Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets 27(4):269–275. https://doi.org/10.3109/09537104.2016.1170112
doi: 10.3109/09537104.2016.1170112
pubmed: 27136385
Maráz A, Furák J, Varga Z, Kahán Z, Tiszlavicz L, Hideghéty K (2013) Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Res 33(4):1725–1729
pubmed: 23564823
Perisanidis C, Mittlböck M, Schoppmann A, Kornek G, Starlinger P, Stift A, Selzer E, Schopper C, Ewers R (2013) Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer. Clin Oral Investig 17(3):913–919. https://doi.org/10.1007/s00784-012-0755-8
doi: 10.1007/s00784-012-0755-8
pubmed: 22643871
Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumor metastasis. Nat Rev Cancer 11(2):123–134. https://doi.org/10.1038/nrc3004
doi: 10.1038/nrc3004
pubmed: 21258396
pmcid: 6894505
Ghanavat M, Ebrahimi M, Rafieemehr H, Maniati M, Behzad MM, Shahrabi S (2019) Thrombocytopenia in solid tumors: prognostic significance. Oncol Rev 13(1):413. https://doi.org/10.4081/oncol.2019.413
doi: 10.4081/oncol.2019.413
pubmed: 31205603
pmcid: 6542370
Liebman HA (2014) Thrombocytopenia in cancer patients. Tromb Res 133:S63–S69. https://doi.org/10.1016/S0049-3848(14)50011-4
doi: 10.1016/S0049-3848(14)50011-4
Krauth MT, Puthenparambil J, Lechner K (2012) Paraneoplastic autoimmune thrombocytopenia in solid tumors. Crit Rev Oncol Hematol 81(1):75–81. https://doi.org/10.1016/j.critrevonc.2011.02.004
doi: 10.1016/j.critrevonc.2011.02.004
pubmed: 21515071
Assinger A, Schrottmaier WC, Salzmann M, Rayes J (2019) Platelets in sepsis: an update on experimental models and clinical data. Front Immunol 10:1687. https://doi.org/10.3389/fimmu.2019.01687
doi: 10.3389/fimmu.2019.01687
pubmed: 31379873
pmcid: 6650595
Cheng L, DeJesus AY, Rodriguez MA (2017) Using laboratory test results at hospital admission to predict short-term survival in critically ill patients with metastatic or advanced cancer. J Pain Symptom Manag 53(4):720–727. https://doi.org/10.1016/j.jpainsymman.2016.11.008
doi: 10.1016/j.jpainsymman.2016.11.008
Okugawa Y, Shirai Y, Nodono H, Matsutani F, Itoh M, Hishida A, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Araki T, Inoue Y, Tanaka M, Kusunoki M, Miki C (2017) Objective predictive score as a feasible biomarker for short-term survival in terminally ill patients with cancer. Anticancer Res 37(1):267–275. https://doi.org/10.21873/anticanres.11317
doi: 10.21873/anticanres.11317
pubmed: 28011502
Ohde S, Hayashi A, Takahashi O, Yamakawa S, Nakamura M, Osawa A, Shapiro ML, Deshpande GA, Tokuda Y, Omata F, Ishida Y, Soejima K, Hinohara S, Fukui T (2011) A 2 week prognostic prediction model for terminal cancer patients in a palliative care unit at a Japanese general hospital. Palliat Med 25(2):170–176. https://doi.org/10.1177/0269216310383741
doi: 10.1177/0269216310383741
pubmed: 20929929
Hausner D, Kevork N, Pope A, Hannon B, Bryson J, Lau J, Robin G, Le LW, Zimmermann C (2018) Factors associated with discharge disposition on an acute palliative care unit. Support Care Cancer 26(11):3951–3958. https://doi.org/10.1007/s00520-018-4274-2
doi: 10.1007/s00520-018-4274-2
pubmed: 29850945